EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, ASRT: Assertio Therapeutics Inc

31 Oct 25 15:59
LAST:

0.7429

CHANGE:
 0.01		OPEN:
0.7718		HIGH:
0.7718		ASK:
0.0000		VOLUME:
233.5K
CHG(%):
1.21		PREV:
0.7520		LOW:
0.7300		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
31 Oct 250.77180.77180.73000.7429233.5K
30 Oct 250.76400.77180.74600.7520253.3K
29 Oct 250.82000.82000.76870.7718337.9K
28 Oct 250.81000.82000.80140.8129303.9K
27 Oct 250.81100.82000.80900.8113218.0K
24 Oct 250.81500.82990.81500.820179.4K
23 Oct 250.81000.82980.80540.8200101.3K
22 Oct 250.83000.83000.81000.8100184.3K
21 Oct 250.81950.84680.80500.8302134.3K
20 Oct 250.80500.84000.80100.8295223.4K

COMPANY PROFILE

Name:Assertio Therapeutics Inc
About:Assertio Holdings, Inc., a pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat patients with severe, active rheumatoid arthritis, and active polyarticular juvenile idiopathic arthritis, as well as treat adult with severe, recalcitrant, and disabling psoriasis; and ROLVEDON, a long-acting granulocyte colony-stimulating factor that is indicated to decrease the incidence of infection caused by febrile neutropenia. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 2020 and is headquartered in Lake Forest, Illinois.
Sector:Healthcare
Address:100 South Saunders Road, Lake Forest, IL, United States, 60045
Website:https://www.assertiotx.com
CUSIP:04545L107
CIK:0001005201
ISIN:US04546C2052
FIGI:BBG00T442DS2

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.784.8%
MA10:0.807.7%
MA20:0.8311.5%
MA50:0.8413.5%
MA100:0.774.1%
MA200:0.740.1%
RSI14:27.88 
WPR14:-100.00 
MTM14:-0.12
ROC14:-0.14 
ATR:0.03 
Week High:0.8311.7%
Week Low:0.731.8%
Month High:0.9325.2%
Month Low:0.730.1%
Year High:1.0845.4%
Year Low:0.5145.7%
Volatility:5.84 

RECENT SPLITS

Date Ratio
18 May 20211-4